Compare IFRX & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFRX | DHX |
|---|---|---|
| Founded | 2007 | 1991 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.1M | 81.1M |
| IPO Year | 2017 | 2007 |
| Metric | IFRX | DHX |
|---|---|---|
| Price | $1.14 | $1.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $8.50 | $4.75 |
| AVG Volume (30 Days) | ★ 765.5K | 248.2K |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $73,729.00 | ★ $131,236,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,075.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $1.21 |
| 52 Week High | $2.77 | $3.34 |
| Indicator | IFRX | DHX |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 32.06 |
| Support Level | $0.96 | $1.53 |
| Resistance Level | $1.16 | $1.78 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 88.08 | 21.43 |
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.